Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry von Meca-Lallana, J. E, Oreja-Guevara, C, Muñoz, D, Olascoaga, J, Pato, A, Ramió-Torrentà, L, Meca-Lallana, V, Hernández, M. A, Marzo, M. E, Álvarez- Cermeño, J. C, Rodríguez-Antigüedad, A, Montalbán, X, Fernández, O

Volltext

Clinically isolated syndromes : A new oligoclonal band test accurately predicts conversion to MS von MASJUAN, J, ALVAREZ-CERMENO, J. C, GARCIA-BARRAGAN, N, DIAZ-SANCHEZ, M, ESPINO, M, SADABA, M. C, GONZALEZ-PORQUE, P, MARTINEZ SAN MILLAN, J, VILLAR, L. M

Volltext

An ultrasensitive method for the detection of oligoclonal IgG bands von Sádaba, M.C., González Porqué, P., Masjuan, J., Álvarez-Cermeño, J.C., Bootello, A., Villar, L.M.

Volltext

Tamoxifen: A new risk factor for cerebral sinus thrombosis von MASJUAN, J, PARDO, J, CALLEJO, J. M, ANDRES, M. T, ALVAREZ-CERMENO, J. C

Volltext

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study von Leurs, CE, Twaalfhoven, HAM, Lissenberg-Witte, BI, van Pesch, V, Dujmovic, I, Drulovic, J, Castellazzi, M, Bellini, T, Pugliatti, M, Kuhle, J, Villar, LM, Alvarez-Cermeño, JC, Alvarez-Lafuente, R, Hegen, H, Deisenhammer, F, Walchhofer, LM, Thouvenot, E, Comabella, M, Montalban, X, Vécsei, L, Rajda, C, Galimberti, D, Scarpini, E, Altintas, A, Rejdak, K, Frederiksen, JL, Pihl-Jensen, G, Jensen, PEH, Khalil, M, Voortman, MM, Fazekas, F, Saiz, A, La Puma, D, Vercammen, M, Vanopdenbosch, L, Uitdehaag, BMJ, Killestein, J, Bridel, C, Teunissen, C

Volltext

Influence of oligoclonal IgM specificity in multiple sclerosis disease course von Villar, LM, García-Barragán, N., Espiño, M., Roldán, E., Sádaba, MC, Gómez-Rial, J., González-Porqué, P., Álvarez-Cermeño, JC

Volltext

Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis von Alcázar, A., Regidor, I., Masjuan, J., Salinas, M., Álvarez-Cermeño, J.C.

Volltext

Caspase inhibitors protect against neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients von Cid, C, Álvarez-Cermeño, J.C, Regidor, I, Plaza, J, Salinas, M, Alcázar, A

Volltext

Interferon beta-1b treatment in patients with relapsing-remitting multiple sclerosis under a standardized protocol in Spain von Arbizu, T., Álvarez-Cermeño, J. C., Decap, G., Fernández, O., Uría, D. F., García Merino, A., Izquierdo, G., Montalbán, X.

Volltext

Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS von VILLAR, L. M, MASJUAN, J, GONZALEZ-PORQUE, P, PLAZA, J, SADABA, M. C, ROLDAN, E, BOOTELLO, A, ALVAREZ-CERMENO, J. C

Volltext

Intrathecal IgM synthesis in neurologic diseases: Relationship with disability in MS von VILLAR, L. M, MASJUAN, J, GONZALEZ-PORQUE, P, PLAZA, J, SADABA, M. C, ROLDAN, E, BOOTELLO, A, ALVAREZ-CERMENO, J. C

Volltext

The expression of integrins on activated T-cells in multiple sclerosis. Effect of intravenous methylprednisolone treatment von Luján, S, Masjuan, J, Roldán, E, Villar, L M, González-Porqué, P, Álvarez-Cermeño, J C

Volltext

A sensitive and reproducible method for the detection of oligoclonal IgM bands von Villar, L.M, González-Porqué, P, Masjuán, J, Alvarez-Cermeño, J.C, Bootello, A, Keir, G

Volltext

Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the ‘hygiene hypothesis’? von Alari‐Pahissa, E., Moreira, A., Zabalza, A., Alvarez‐Lafuente, R., Munteis, E., Vera, A., Arroyo, R., Alvarez‐Cermeño, J. C., Villar, L. M., López‐Botet, M., Martínez‐Rodríguez, J. E.

Volltext

Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis von Villar, L. M., Picón, C., Costa-Frossard, L., Alenda, R., García-Caldentey, J., Espiño, M., Muriel, A., Álvarez-Cermeño, J. C.

Volltext

Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis von Rodríguez‐Martín, E., Picón, C., Costa‐Frossard, L., Alenda, R., Sainz de la Maza, S., Roldán, E., Espiño, M., Villar, L. M., Álvarez‐Cermeño, J. C.

Volltext

Clinical usefulness of prognostic biomarkers in optic neuritis von Tejeda‐Velarde, A., Costa‐Frossard, L., Sainz de la Maza, S., Carrasco, Á., Espiño, M., Picón, C., Toboso, I., Walo, P. E., Lourido, D., Muriel, A., Álvarez‐Cermeño, J. C., Villar, L. M.

Volltext

Early beginning of alemtuzumab: Changing the multiple sclerosis treatment paradigm. Interim analysis of the LEMVIDA study von Meca-Lallana, J.E., Álvarez-Cermeño, J.C., Casanova Estruch, B., Izquierdo Ayuso, G., Ortiz Castillo, R., Rodríguez-Antigüedad, A., Calles Hernández, C.

Volltext

Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index von de Bock, L., Fraussen, J., Villar, L. M., Álvarez-Cermeño, J. C., Van Wijmeersch, B., van Pesch, V., Stinissen, P., Somers, V.

Volltext

Identification of the major HHV-6 antigen recognized by cerebrospinal fluid IgG in multiple sclerosis von Alenda, R., Álvarez-Lafuente, R., Costa-Frossard, L., Arroyo, R., Mirete, S., Álvarez-Cermeño, J. C., Villar, L. M.

Volltext